Skip to main content

Table 2 General distribution of patients with diabetes mellitus by primary care center (PCC).

From: Use of aspirin for primary and secondary prevention of cardiovascular disease in diabetic patients in an ambulatory care setting in Spain

Variables

PCC-1 n = 978

PCC-2 n = 1,486

PCC-3 n = 902

PCC-4 n = 774

p

CVD (events, %)

22.2

20.7

20.0

21.1

ns

Use of ASA (%)

29.1

35.3

20.0

28.2

0.000

Sex (males, %)

46.9

51.5

46.8

50.9

0.041

Mean age (SD), years

62.2 (14.2)

64.1 (13.5)

65.5 (13.5)

64.9 (13.9)

0.000

CV history

     

Hypertension

49.4

51.2

55.8

50.0

0.002

Hypercholesterolemia

35.8

39.5

37.7

36.2

ns

Active smoking

21.6

17.7

18.3

17.2

ns

Obesity (BMI < 29)

48.5

46.9

46.4

43.9

ns

Therapeutic targets

     

BP (<130/80 mmHg)

49.6

37.4

50.1

57.6

0.002

Total cholesterol (<200 mg/dL)

50.6

50.7

41.1

45.0

0.000

LDL-C (<100 mg/dL)

20.6

21.7

13.5

17.1

0.000

Glycated HbA1c (<6.5%)

33.3

34.4

32.0

33.6

ns

  1. Values are given as percentage or mean (SD: standard deviation); p: statistical significance; CVD: cardiovascular disease; ASA: acetyl salicylic acid; CV: cardiovascular; BMI: body mass index; BP: blood pressure (mmHg); LDL-C: low density lipoprotein cholesterol (mg/dL); Hb: hemoglobin.